Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cara A. Rosenbaum, MD
University of Chicago
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Cleveland Clinic Florida - Weston
Weston, Florida, United States
- Illinois Cancercare - Bloomington
Bloomington, Illinois, United States
- Illinois Cancercare - Canton
Canton, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Illinois Cancercare - Eureka
Eureka, Illinois, United States
- Galesburg Clinic, Pc
Galesburg, Illinois, United States
- Illinois Cancercare - Macomb
Macomb, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
- Community Cancer Center
Normal, Illinois, United States
- Illinois Cancercare - Community Cancer Center
Normal, Illinois, United States
- Community Hospital of Ottawa
Ottawa, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Ottawa
Ottawa, Illinois, United States
- Cancer Treatment Center at Pekin Hospital
Pekin, Illinois, United States
- Illinois Cancercare - Pekin
Pekin, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Peoria
Peoria, Illinois, United States
- Proctor Hospital
Peoria, Illinois, United States
- Illinois Cancercare - Peru
Peru, Illinois, United States
- Illinois Valley Community Hospital
Peru, Illinois, United States
- Illinois Cancercare - Spring Valley
Spring Valley, Illinois, United States
- Iowa Blood and Cancer Care
Cedar Rapids, Iowa, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
- Mecosta County Medical Center
Big Rapids, Michigan, United States
- Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Lacks Cancer Center at Saint Mary'S Health Care
Grand Rapids, Michigan, United States
- Mercy General Health Partners
Muskegon, Michigan, United States
- Spectrum Health Reed City Hospital
Reed City, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- New Hampshire Oncology - Hematology, Pa at Payson Center for Cancer Care
Concord, New Hampshire, United States
- New Hampshire Oncology - Hematology, Pa - Hooksett
Hooksett, New Hampshire, United States
- Lakes Region General Hospital
Laconia, New Hampshire, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Monter Cancer Center of the North Shore-Lij Health System
Lake Success, New York, United States
- Don Monti Comprehensive Cancer Center at North Shore University Hospital
Manhasset, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2011
- Primary completion
- 31 Mar 2015
- Completion
- 15 Oct 2020
- Last update posted
- 18 Aug 2021
- Registered enrollment
- 51
- Registry id
- NCT01190449
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.